期刊文献+

胰岛素泵强化治疗对初诊2型糖尿病的疗效观察 被引量:6

The Therapeutic Effect of the Insulin Pump Intensive Therapy of Newly-Diagnosed Type 2 Diabetes Mellitus(T2DM) Patients
原文传递
导出
摘要 目的:观察胰岛素泵强化治疗对合并肥胖和高脂血症的初诊2型糖尿病(T2DM)患者的疗效。方法:采用胰岛素泵持续皮下输注(CS‖)超短效门冬胰岛素(诺和锐)强化治疗15天(15d)54例合并肥胖和高脂血症的新诊断T2DM患者,分别在强化治疗15d结束时和继治疗90d时观察患者的血糖、糖化血红蛋白、血脂、体重指数和反应胰岛β细胞功能的胰岛素和C肽指标改变情况。结果:在强化治疗15d撤泵时和治疗90d后患者血糖明显下降;而糖化血红蛋白、血脂、体重指数、胰腺β细胞功能在治疗90d时改善明显。结论:早期胰岛素泵强化治疗新诊断的2型糖尿病(T2DM)患者,不仅可使其血糖尽早达标,而且还可明显降低血脂和体重指数、糖化血红蛋白,并使部分患者胰岛β细胞功能恢复,一段时期内脱离药物治疗,提高生活质量。 Objective:To observe the therapeutic effect of the insulin pump intensive therapy of Newly-diagnosed type 2 diabetes mellitus(T2DM) patients merge with obesity and hyperlipidemia.Methods:The indices of blood sugar and glycated hemoglobin,blood Lipid,body mass index,insulin and c-peptide were observed respectively after 15 days of Insulin pump intensive treatment and after 90 days when the patients insulin pump was removed to.Results:The blood glucose decreased obviously in from pump and treat patients after 90 days.And glycated hemoglobin,blood Lipid,body mass index,pancreatic beta cells function got obviously better results after 90 days of treatment.Conclusion:Early insulin pump strengthening treatment of type 2 diabetes mellitus(T2DM) patients,not only can make its blood sugar standard as soon as possible,but also can obviously decrease the blood lipid and body mass index,and to make some cases with pancreatic beta cells function recovery,a period seprating theirself from drug therapy,improve life quality.
出处 《现代生物医学进展》 CAS 2012年第36期7116-7119,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30670781)
关键词 糖尿病 胰岛素泵 强化治疗 血糖 血脂 Type 2 diabetes Insulin pump Strengthening treatment Blood sugar Blood Lipid
  • 相关文献

参考文献7

二级参考文献61

  • 1乔媛,王养维.甘精胰岛素用于Ⅱ型糖尿病患者术后血糖控制的探讨[J].微量元素与健康研究,2009,26(1):11-13. 被引量:2
  • 2SAYDAH S H, FRADKIN J, COWIE C C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes [ J ]. JAMA, 2004,291 : 335-342.
  • 3UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33 ) [ J ]. Lancet, 1998,352 : 837-853.
  • 4STRATTON I M, ADLER A I, NEIL H A, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study [ J ]. BMJ,2000,321:405-412.
  • 5Asia Pacific Type 2 Diabetes Policy Group. Type 2 diabetes practical targets and treatments [ M ]. 3rd. Sydney: Health Communications Australia Pty Limited and in vivo Communications Pty Limited, 2002 : 293.
  • 6GRUNDY S M, CLEEMAN JI, MERZ CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines [ J ]. J Am Coil Cardiol, 2004,44:720-732.
  • 7SOWERS J R, BAKRIS G L. Antihypertensive therapy and the risk of type 2 diabetes mellitus [ J ]. N Engl J Med, 2000,342 : 969-970.
  • 8ADLER A I, STRATrON I M, NEIL H A, et al. Association of systolic blood pressure with macrovascular and microvascular complications on type 2 diabetes (UKPDS 36 ): prospective observational study [ J]. BMJ,2000,321:412-419.
  • 9Fox CS,Coady S, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus:the Framingham Heart Study [J]. Circulation, 2007,115(12) : 1544-50.
  • 10Kamaua AM,Grady D,Barrett-Connor E.Explaining the sex difference in coronary heart disease mortality among patients with type 2 diatetes mellitus:a meta-analysis [J]. Arch Intern Med,2002,162 ( 15): 1737-1745.

共引文献1342

同被引文献37

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部